image credit: Pixabay

Moderna stock surges after company announces promising coronavirus vaccine trial data

July 15, 2020


Moderna’s stock surged 12% on Wednesday after the biotech company released promising data on its potential coronavirus vaccine trial, saying it generated a “robust” immune response.

The vaccine candidate produced neutralizing antibodies, which scientists believe is important for building immunity against the virus, in all 45 patients tested in the trial, Moderna scientists reported Tuesday night in the New England Journal of Medicine. Additionally, the antibodies that were produced were higher than those seen in people who have recovered from Covid-19.

Read More on CNBC